Which agent and dose would you prescribe, and for which trimester would you recommend use?
Here’s a full list of the contents of the latest issue of Pharma.
About one half of all people with uveal melanoma will suffer a recurrence of the disease.
What is your diagnosis? What is your management?
Associate Professors Mark Roth and Graham Lee discuss the next generation in non-steroidal anti-inflammatory agents, nepafenac 0.3% suspension (Ilevro).
An investigation finds a link between cataracts, falls and depressive symptoms.
A rare complication results when a scleral tunnelling technique provides an entry point for an eyelash.
Understand the benefits and limitations of tonometry techniques.
Read about the latest research papers, news and reviews.
Therapeutic treatment, management options and recommendations for the most common occupational-related ocular injury in Australia.
Advanced imaging yields a growing number of indicators.
This Chair-side Reference will assist optometrists to distinguish the different stages and phenotypes of age-related macular degeneration.
Research investigates the role of outdoor activity in myopia
Atropine is an effective way to control myopia and a good alternative to other treatment options.